PTC Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
PTC Therapeutics, Inc. (PTCT) reported Increase (Decrease) in Deferred Revenue of $1.41 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-05-09
- PTC Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was $1.41M, a 142.10% increase year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$1.24M, a 263.72% decline year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $6.11M, a 3273.48% increase year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $4.02M, a 1069.19% increase year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2017 was $9.47M, a 520.51% increase from fiscal 2016.
- PTC Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2016 was $1.53M.
- PTC Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$3.31M, a 233.56% decline from fiscal 2014.
- PTC Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2014 was $2.48M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-03-31 | $1.41M 10-Q · filed 2018-05-09 | $168.00K derived: sum of 2 quarters · filed 2018-05-09 | $6.27M derived: sum of 3 quarters · filed 2018-05-09 | $10.30M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2017-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $4.87M derived: sum of 2 quarters · filed 2018-03-06 | $8.89M derived: sum of 3 quarters · filed 2018-03-06 | $9.47M 10-K · filed 2018-03-06 | |||
| 2017-09-30 | $6.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $10.13M derived: sum of 2 quarters · filed 2017-11-02 | $10.71M 10-Q · filed 2017-11-02 | $11.47M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2017-06-30 | $4.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $4.60M 10-Q · filed 2017-08-09 | $5.36M derived: sum of 3 quarters · filed 2018-05-09 | $5.54M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2017-03-31 | $582.00K 10-Q · filed 2018-05-09 | $1.34M derived: sum of 2 quarters · filed 2018-05-09 | $1.52M derived: sum of 3 quarters · filed 2018-05-09 | $1.86M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | $758.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $939.00K derived: sum of 2 quarters · filed 2018-03-06 | $1.28M derived: sum of 3 quarters · filed 2018-03-06 | $1.53M 10-K · filed 2018-03-06 | |||
| 2016-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $525.00K derived: sum of 2 quarters · filed 2017-11-02 | $768.00K 10-Q · filed 2017-11-02 | $771.00K derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-06-30 | $344.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $587.00K 10-Q · filed 2017-08-09 | $590.00K derived: sum of 3 quarters · filed 2018-03-06 | $634.00K derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-03-31 | $243.00K 10-Q · filed 2017-05-08 | $246.00K derived: sum of 2 quarters · filed 2018-03-06 | $290.00K derived: sum of 3 quarters · filed 2018-03-06 | -$83.00K derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2015-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $47.00K derived: sum of 2 quarters · filed 2018-03-06 | -$326.00K derived: sum of 3 quarters · filed 2018-03-06 | -$3.31M 10-K · filed 2018-03-06 | |||
| 2015-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$329.00K derived: sum of 2 quarters · filed 2016-11-03 | -$3.31M 10-Q · filed 2016-11-03 | -$725.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | -$373.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$3.35M 10-Q · filed 2016-08-04 | -$769.00K derived: sum of 3 quarters · filed 2017-03-16 | -$242.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | -$2.98M 10-Q · filed 2016-05-05 | -$396.00K derived: sum of 2 quarters · filed 2017-03-16 | $131.00K derived: sum of 3 quarters · filed 2017-03-16 | -$119.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $3.11M derived: sum of 2 quarters · filed 2017-03-16 | $2.86M derived: sum of 3 quarters · filed 2017-03-16 | $2.48M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $527.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $277.00K derived: sum of 2 quarters · filed 2015-11-09 | -$109.00K 10-Q · filed 2015-11-09 | -$2.86M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | -$250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$636.00K 10-Q · filed 2015-07-31 | -$3.39M derived: sum of 3 quarters · filed 2016-02-29 | -$6.98M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$386.00K 10-Q · filed 2015-05-05 | -$3.14M derived: sum of 2 quarters · filed 2016-02-29 | -$6.73M derived: sum of 3 quarters · filed 2016-02-29 | -$12.03M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$6.35M derived: sum of 2 quarters · filed 2016-02-29 | -$11.65M derived: sum of 3 quarters · filed 2016-02-29 | -$16.55M 10-K · filed 2016-02-29 | -$16.55M 10-K · filed 2014-03-06 | ||
| 2013-09-30 | -$3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$8.89M derived: sum of 2 quarters · filed 2014-11-06 | -$13.80M 10-Q · filed 2014-11-06 | -$13.80M 10-Q · filed 2013-11-14 | -$19.06M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | -$5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$10.21M 10-Q · filed 2014-08-07 | -$10.21M 10-Q · filed 2013-08-13 | -$15.47M derived: sum of 3 quarters · filed 2015-03-02 | -$21.12M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | -$4.91M 10-Q · filed 2014-05-06 | -$10.17M derived: sum of 2 quarters · filed 2015-03-02 | -$15.82M derived: sum of 3 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | -$5.26M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$10.91M derived: sum of 2 quarters · filed 2015-03-02 | -$21.97M 10-K · filed 2015-03-02 | -$21.97M 10-K · filed 2014-03-06 | |||
| 2012-09-30 | -$5.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$16.71M 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | -$11.06M 10-Q · filed 2013-08-13 | ||||||
| 2011-12-31 | -$55.00M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |